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Abstract
On the U.S.-Mexico border, residents frequently cross into Mexico to obtain medications or 
medical care. We previously reported relatively high prevalence of hypertension among Latina 
oral contraceptive users in El Paso, particularly those obtaining pills over the counter (OTC) in 
Mexico. Here, we examine factors associated with having hypertension among 411 OTC users and 
399 clinic users. We also assess hypertension awareness and interest in using blood pressure 
kiosks. Women age 35 to 44 and who had BMI ≥ 30 kg/m2 had higher odds of having 
hypertension. 59% of hypertensive women had unrecognized hypertension, and 77% of all 
participants would use a blood pressure kiosk; there were no significant differences between clinic 
and OTC users. Alternative approaches to increase access to health screenings are needed in this 
setting, where OTC pill use among women with unrecognized hypertension confers unique health 
risks.
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Many studies have documented that Latinos living in cities and states along the U.S.-Mexico 
border frequently cross into Mexico to purchase medications or obtain health and medical 
services.1–5 In a representative sample of California residents, Wallace et al. found that 11% 
of Mexican-origin adults in the state obtained medical or dental services or medications in 
Mexico in the previous year.5 Several other studies conducted in U.S. cities and counties 
located just across the border from Mexico found that between 20% and 50% of sampled 
participants reported cross-border use of health services or purchase of medications in the 
last year.1–4,6,7
A common finding in these studies is that individuals who lack health insurance are more 
likely to cross into Mexico for services, where the cost of care is typically lower than that in 
US health care settings.2,4–7 These results indicate that health services in Mexico represent 
an important safety net for low-income and under- or uninsured border residents. However, 
some authors argue that these U.S. residents still lack access to a full range of services as 
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they primarily use health care in Mexico for specific health needs (e.g., minor emergencies 
and dental care).4 As a result, they may not be receiving important preventive and primary 
health care services.
In a recent prospective cohort study of El Paso resident women using oral contraceptive 
pills, we found that those who obtained their method over the counter (OTC) at Mexican 
pharmacies were less likely to have health insurance than women who obtained pills at U.S. 
clinics and health centers.8 Over-the-counter pill users in this sample had clear reasons for 
preferring the cross-border option, the most common of which was the perceived lower cost 
of pills in Mexico. Although OTC users were less likely than U.S. clinic users to report a 
regular source of health care, the vast majority had received important reproductive health 
screenings such as Pap smears and testing for sexually transmitted infections.9
However, we also found that OTC users in this sample were more likely than US clinic users 
to have medical conditions considered contraindications to use of combined oral 
contraceptive pills (COCs).10 Hypertension, which increases risk of myocardial infarction 
and stroke among women using COCs,11–13 was the most common contraindication 
identified. Although we observed a higher prevalence among OTC users compared to clinic 
users, hypertension was higher in both groups than other samples of reproductive aged 
women using oral contraceptives.14 This finding suggests that there is likely a large amount 
of unrecognized hypertension in this population.
In this article, we conduct a more detailed analysis of hypertension in this sample of 
combined oral contraceptive users. Specifically we assess the factors associated with having 
hypertension as well as women’s awareness of the condition. Since obtaining pills OTC in 
Mexico may be an indicator of women’s lack of access to regular care (where they would 
receive blood pressure screening) we also report on women’s interest in using kiosks outside 
of clinics to measure their blood pressure.
Methods
Setting
El Paso, Texas, like many other cities near or along the U.S.-Mexico border, is characterized 
by low incomes and a substantial proportion of the population lacking health insurance. 
According to the 2005–2009 American Community Survey, El Paso’s median household 
income of $36,147 makes it the sixth poorest among U.S. counties with populations greater 
than 250,000.15 An estimated 29% of El Paso’s residents live in poverty.15 Approximately 
35% of El Paso adults age 18 and older lack health insurance,16 and the percentage of adult 
Latinos without insurance is even higher.17
Low-income and under- or uninsured reproductive aged women in El Paso can access 
reproductive health services through U.S. health clinics and centers where state-
administered federally-funded programs enable them to receive contraception and important 
health screenings for little or no cost. Previous research in El Paso also found that a large 
percentage of women cross the border for contraception. Among multiparous women 
delivering in a large El Paso hospital, 50% cited Mexican pharmacies as their contraceptive 
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source prior to pregnancy.1 Oral contraceptive pills were one of the most commonly 
reported methods obtained from pharmacies across the border, where the cost is around $5 
per cycle.
Data
The data for this analysis come from the Border Contraceptive Access Study, a prospective 
cohort study of El Paso resident women between ages 18 and 44 years who were oral 
contraceptive users.18 Women in this study obtained pills from U.S. clinics (n=532) or OTC 
at Mexican pharmacies (n=514).8 Bilingual (English/Spanish) female interviewers recruited 
a portion of the clinic user sample from the main family planning providers in El Paso. The 
remaining clinic sample and entire OTC user sample were recruited using announcements 
and presentations at local community centers, flyers and referrals from other participants. 
Study participants completed a series of four interviews at three-month intervals: a baseline 
face-to-face interview (conducted between December 2006 and February 2008), telephone 
interviews at three and six months after the baseline, and a nine-month face-to-face follow-
up interview. Overall, 941 women (90% of the baseline sample) completed the nine-month 
follow-up interview by the end of data collection in December 2008.
In the baseline interview, participants provided information about basic sociodemographic 
characteristics, their health insurance status, regular source of care, and current oral 
contraceptive use, including pill brand. Interviewers also asked women if they had high 
blood pressure or were taking medication for high blood pressure and the date of their last 
blood pressure measurement. During each follow-up interview, participants were asked to 
report their health insurance status, current contraceptive method, if they had had their blood 
pressure measured since their last interview, and if they were taking medications for 
hypertension.
Having found a high prevalence of hypertension among a sample of reproductive aged 
women in the general population in El Paso,19 we collected more detailed information about 
hypertension and associated risk factors in the nine-month interview. Specifically, 
interviewers asked women whether they had ever been told by a doctor, nurse, or other 
health professional that they had hypertension, where they last had their blood pressure 
measured, and whether they thought hypertension was very serious, somewhat serious, or 
not a serious problem. Participants were also asked to report if they had ever smoked or 
currently smoked cigarettes, if they had engaged in any moderate exercise in the last 30 days 
and, if so, the number of times per week. Moderate exercise was assessed as any physical 
activity that lasted at least 10 minutes and caused sweating or an increase in heart rate or 
breathing. Additionally, interviewers showed participants a picture of a blood pressure kiosk 
and asked if they would be interested in having their blood pressure checked at a similar 
kiosk. Those interested in using a kiosk were asked if they would consider paying a small 
fee to have their blood pressure measured and, if so, how much they would pay. Those not 
interested in using the kiosk were asked why they were not interested.
At the end of the nine-month follow-up interview, interviewers also measured participants’ 
height, weight, and blood pressure. Participants’ height was measured using a Seca Road 
Rod 214 stadiometer, and their weight was measured using a Seca Clara 803 digital scale 
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(Seca Corporation). Using these height and weight measurements, we calculated women’s 
body mass index (BMI, calculated as weight (kg)/[height (m)]2). For women missing height 
and/or weight measurements at the final interview (n=181), we calculated BMI using their 
self-reported height and weight at the baseline interview. A small number of participants 
(n=38) were missing both self-reported height and weight, as well as the nine-month 
interview measurements. We categorized participants into three groups: normal weight (< 
25.0 kg/m2), overweight (25.0–29.9 kg/m2), and obese (≥ 30.0 kg/m2).
Interviewers were trained to measure participants’ blood pressure using an automated 
Omron HEM 705CP blood pressure monitor (Omron Healthcare, Bannockburn, IL). They 
took two blood pressure measurements five minutes apart and recorded the mean systolic 
and diastolic blood pressure. We classified women as having hypertension if their average 
systolic blood pressure was ≥140 mm Hg, their average diastolic blood pressure was ≥90 
mm Hg, or if their average blood pressure was <140/90 mm Hg and they were taking 
medication for high blood pressure.13 If a woman with blood pressure ≥140/90 mm Hg 
reported having ever been told by a doctor, nurse, or other health professional that she had 
hypertension, we considered her aware of her condition.
Participants provided written informed consent before completing the baseline interview and 
received gift cards valued between $10 and $35 for each interview they completed. Women 
who had a high blood pressure measurement at the nine-month follow-up interview, or other 
self-reported contraindications to pill use at any interview, were given a referral to a health 
care provider. This study was approved by the institutional review boards at the appropriate 
institutions.
For the current study, we restricted the original sample of 1,046 women to those who 
completed the nine-month interview, who were not pregnant at the time of the interview and 
had a valid blood pressure measurement (n=836). Since hypertension is only considered a 
contraindication to COCs, we excluded women who reported using progestin-only pills 
(n=12) or did not report a pill brand (n=8) at baseline. Women missing information on 
sociodemographic characteristics or BMI (n=6) were also excluded. Our final analytic 
sample included 399 clinic users and 411 OTC users, 89% of whom were still using COCs 
at the nine-month interview.
Statistical analysis
We compared women’s sociodemographic characteristics and the proportion having 
hypertension and the proportion who were told they had hypertension separately for clinic 
and OTC pill users. The statistical significance of differences in proportions was determined 
using chi-squared tests. Using logistic regression, we estimated crude and multivariable 
adjusted odds ratios for having hypertension based on the average blood pressure reading at 
the nine-month follow-up interview. In addition to source of COCs at baseline, our 
multivariable model included women’s age, BMI, smoking status, and whether she had a 
source of regular care as these factors have been associated with hypertension in this 
population and other samples with Latina women.19–21 We also assessed the proportion of 
women interested in using a kiosk for blood pressure measurements according to their 
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sociodemographic characteristics. All analyses were conducted using Stata 11.0 (StataCorp 
LP, College Station, TX).
Results
Compared with clinic users, OTC users were older and more likely to have had children, to 
have less than a high school level education, and to have been born in Mexico (Table 1). 
With respect to indicators of access to care, OTC users were less likely than clinic users to 
have U.S. health insurance and to report having a regular source of care. Approximately 
one-third of women did not engage in moderate exercise in the last 30 days and just over 
two-thirds were overweight or obese; there were no significant differences between clinic 
and OTC users. Although relatively few women were current smokers, a slightly higher 
percentage of OTC users than clinic users reported that they smoked.
Additionally, OTC users were less likely than clinic users to have had their blood pressure 
checked in the last two years. Among those who had a recent blood pressure measurement, 
83.0% of clinic users and 50.3% of OTC users did so at a clinic or doctor’s office in the 
U.S.; 15.5% of OTC users reported their last blood pressure measurement was at a clinic or 
doctor’s office in Mexico (results not shown). Health fairs, work sites, community centers, 
and pharmacy kiosks were also mentioned as other places where women last had their blood 
pressure measured.
Overall, 7.0% of clinic users and 10.5% of OTC users had hypertension (Crude OR: 1.55, 
95% confidence interval 0.94–2.55, p=.085). After multivariable adjustment, the odds ratio 
for OTC users was 1.38 (95% confidence interval 0.82–2.35) (Table 2). Compared with 
women ages 18 to 34, women who were 35 years or older were more likely to have 
hypertension. In addition, women with a BMI ≥ 30.0 kg/m2 had significantly higher odds of 
hypertension than those with BMI < 25.0 kg/m2 (OR: 6.05, 95% confidence interval 2.50–
14.6). Women’s smoking status and having a regular source of care were not significantly 
associated with having hypertension.
Among women with hypertension, 59.1% said they had never been told they had high blood 
pressure (results not shown). There were no significant differences in awareness between 
clinic and OTC users. We also did not identify any significant associations between 
hypertension awareness and age, health insurance, BMI or perceived seriousness of 
hypertension. Although a higher percentage of women who had a usual source of care were 
considered aware that they had hypertension, just over half (55.3%) reported having ever 
been told they had high blood pressure.
When asked if they would be interested in using a kiosk to have their blood pressure 
measured, 76.9% of women responded that they would. We did not identify any significant 
associations in demographic characteristics or indicators of health care access and interest in 
using a kiosk. Of those interested in using a kiosk, 86.2% said they would be willing to pay 
a small fee (e.g., <$5.00) to have their blood pressure checked. Of those not interested in the 
kiosk (n=187), the most commonly reported reasons were that they would prefer to see a 
doctor or go to the clinic (34.2%), would not trust the measurement (30.5%), and did not 
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think the kiosk was private (10.2%). Other reasons women mentioned for not being 
interested included that they would not understand the blood pressure reading, did not think 
they were at risk for high blood pressure, or checked their blood pressure at home or work.
Discussion
Compared with other studies of reproductive aged women using oral contraceptives,14 we 
found a higher prevalence of hypertension in this sample of women using COCs. This was 
true for both women who obtained pills at U.S. clinics and those who obtained their method 
OTC in Mexico, although the prevalence of hypertension was somewhat higher among OTC 
users. This may be due, in part, to the older age of women in our sample; however, the 
hypertension prevalence we observed was also higher than that reported for women ages 35 
to 44 using oral contraceptives in the Behavioral Risk Factor Surveillance System.22 The 
large proportion of participants who were overweight and obese also contributes to our 
findings, as higher BMI is a significant risk factor for having hypertension.20,23
Additionally, we found high levels of unrecognized hypertension among those women who 
had high blood pressure, but awareness of having hypertension was not significantly 
different for clinic and OTC users. It may be that when women get their blood pressure 
measured, they receive limited information about the potential risks associated with using 
COCs if they have hypertension. Almost one-fifth of clinic users and one-third of OTC users 
who had their blood pressure checked in the last two years did so outside a clinical setting, 
and therefore may not have been asked about their current contraceptive use. Although 
women in this sample did recognize hypertension as a serious health problem in general, 
they likely do not believe they are at risk at younger ages and may not have adequate 
information about other important risk factors. 24 Given that other studies have also found 
hypertension awareness is low among younger and Mexican-origin women,21,23,25 
additional community-based educational efforts are needed to increase awareness about 
hypertension among reproductive aged women in this population.
It is also a matter for concern that 41% of these women were using oral contraceptives 
despite having been told they had hypertension. This may be because they were unaware 
that hypertension is a contraindication to COC use, or because they had no other options for 
effective contraception and chose the risks of pill use over pregnancy. We are exploring this 
issue in more detail in a related qualitative study of COC users with hypertension in El Paso.
These results highlight the need to improve access to important health screenings in settings 
such as the US-Mexico border. Some women in our sample had not had a blood pressure 
measurement in the last two years, and lack of recent screening was more common among 
OTC users, who are less likely to have regular access to care overall. Although federally 
qualified health centers and safety-net providers in these areas may expand access to care for 
low-income and uninsured populations, these organizations currently do not have the 
capacity to meet the large existing demand for care.26–28 While national health care reform 
may also increase access to screening for groups that currently lack health insurance and 
regular sources of care, a significant portion of the border population may not benefit from 
the reforms due to their immigration status. Therefore, alternative approaches to increase 
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screening for conditions such as hypertension must be considered. Community health 
promoters, or promotores, may be particularly effective at educating this border population 
about and screening for hypertension.29,30
Kiosks in pharmacies or other stores may also be worth considering. Several women in our 
sample reported using pharmacy kiosks for blood pressure measurements, and 
approximately 75% of women stated that they would be interested in using a kiosk and 
would be willing to pay a small fee to have their blood pressure measured. Using a kiosk, 
combined with a validated checklist of contraindications to oral contraceptives,19 may help 
women who obtain their pills OTC in Mexico self-screen for safe oral contraceptive use, 
particularly since previous research has found that pharmacists frequently do not discuss 
contraindications with women obtaining oral contraceptive pills.31 The presence of kiosks in 
pharmacies and other convenient settings on the U.S. side of the border may also help 
increase routine screening among women who are unable to cross back and forth between 
Mexico, due to their immigration status or fear of the increasing violence in Mexico. 
Although it is important that women who self-identify contraindications are able to obtain an 
additional evaluation prior to initiating use, it is worth noting that—for contraindicated 
women—the health risks associated with hypertension would be exacerbated by an 
unintended pregnancy.32
The findings from this study should be interpreted in the context of its limitations. Since we 
only measured women’s blood pressure on a single day, we may have overestimated the 
prevalence of hypertension in this sample. It is possible that some participants experienced 
white coat hypertension (elevated blood pressure in clinical or other similar settings), and 
that the true proportion of women with high blood pressure in this sample is lower than what 
we report here. Additionally, we have limited information about factors associated with 
hypertension awareness and why women who know they have hypertension continue to use 
COCs. As noted above, we are exploring these issues in a related study. Finally, our results 
may not be generalizable to other areas along the U.S.-Mexico border where better access to 
safety-net providers may improve detection and treatment of hypertension among low-
income and uninsured populations. However, given the large number of border communities 
that have primary health professional shortages,28 it is likely that residents in many of these 
areas may be at risk of developing high blood pressure or are unaware that they have 
hypertension.
Conclusion
In the cities and towns along the U.S.-Mexico border where there is a large population of 
low-income and under- and uninsured U.S. residents and limited primary health care 
resources, access to health services in Mexico, including contraception, represents an 
important component of the health care safety net. However, this patchwork of care may 
result in residents having limited information about risk factors for common morbidities 
such as hypertension and lack of consistent, comprehensive care that would permit the 
diagnosis, treatment, and management of these conditions. Over-the-counter use of 
combined oral contraceptives in the context of unrecognized hypertension may put this 
population at particular risk. The uncertain potential of health care reform to extend 
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coverage to many border residents points to a pressing need to develop alternative 
approaches to improve education and health care access for this population.
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Table 1
CHARACTERISTICS OF PARTICIPANTS BY SOURCE OF COMBINED ORAL CONTRACEPTION AT 
BASELINE
US Clinic (n=399) % OTC in Mexico (n=411) % χ2 p-value
Age
 18–24 years 33.6 19.2 <.001
 25–34 years 41.6 41.1
 35–44 years 24.8 39.7
Parity
 0 live births 17.8 10.0 .001
 1 or more live births 82.2 90.0
Education
 Less than High School 46.6 52.8 .079
 High School or more 53.4 47.2
Nativity/Education
 Born and Educated in US 35.6 19.0 <.001
 Born in Mexico, Educated in US 33.1 36.0
 Born and Educated in Mexico 31.3 45.0
US insurance coverage
 No US health insurance 71.4 84.9 <.001
 Has US health insurance 28.6 15.1
Regular source of care
 No regular source of care 46.9 66.4 <.001
 Has a regular source of care 53.1 33.6
Engaged in moderate exercisea
 No moderate exercise 31.8 30.7 .171
 Moderate exercise 1–3 times/week 38.1 33.3
 Moderate exercise ≥ 4 times/week 30.1 36.0
Body Mass Index
 Normal weight (< 25.0 kg/m2) 27.8 27.5 0.298
 Overweight (25.0–29.9 kg/m2) 35.3 40.1
 Obese (≥ 30.0 kg/m2) 36.8 32.4
Smoking
 Non-smoker 69.4 71.3 .058
 Former smoker 18.3 12.9
 Current smoker 12.3 15.8
Last blood pressure measurement
 Within last 2 years 99.0 91.2 <.001
 More than 2 years 1.0 8.8
a
Moderate exercise was defined as having engaged in any physical activity for at least 10 minutes that caused sweating or an increase in heart rate 
or breathing. Women who were unable to engage in moderate exercise (n=1) were included with women who did not report any moderate exercise.
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Table 2
FREQUENCIES AND MULTIVARIABLE ADJUSTED ODDS RATIOS (95% CI) FOR HYPERTENSIONa 
AT THE 9-MONTH FOLLOW-UP INTERVIEW
% AOR (95% CI)
Source of COCs at baseline
 US Clinic 7.0 1.00 (ref)
 OTC in Mexico 10.5 1.38 (0.82–2.35)
Age
 18–34 years 4.9 1.00 (ref)
 35–44 years 16.8 3.47 (2.06–5.87)*
Body Mass Index
 Normal weight (< 25.0 kg/m2) 2.7 1.00 (ref)
 Overweight (25.0–29.9 kg/m2) 6.5 1.97 (0.77–5.06)
 Obese (≥ 30.0 kg/m2) 16.1 6.05 (2.50–14.6)*
Smoking
 Non-smoker 8.2 1.00 (ref)
 Former smoker 8.7 1.03 (0.50–2.12)
 Current smoker 11.4 1.52 (0.76–3.04)
Regular source of care
 No regular source of care 6.1 1.00 (ref)
 Has a regular source of care 10.1 1.48 (0.81–2.68)
*p < .05
aWomen were classified as having hypertension if they had an average systolic blood pressure measurement ≥ 140 mm Hg or average diastolic 
blood pressure measurement of ≥ 90 mm Hg or if they had blood pressure < 140/90 and reported taking medication for hypertension.
AOR = Adjusted Odds Ratio
CI = Confidence Interval
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